Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/10/20 → 9/10/26 |
Funding
- Pharmaceutical Research Associates, Inc. ((IOE) Prot #849-002 // (IOE) Prot #849-002)
- Mirati Therapeutics Inc. ((IOE) Prot #849-002 // (IOE) Prot #849-002)
Prot #849-002: A Phase 1/2 Trial of MRTX849 in Combination with TNO155 in Patients with Advanced Solid Tumors with KRAS G12C Mutation
- Mohindra, Nisha A (PD/PI)
Project: Research project